AHA-JCS Joint Symposium(AHA Scientific Sessions)
■AHA2015(フロリダ)
Recent Progress in Pulmonary Hypertension
座長:Samuel Dudley (Provience, RI)
佐藤 徹先生(杏林大学 循環器内科)
演者:
1.Pulmonary Angioplasty as an Alternative Treatment for Inoperable Patients With
Chronic Thromboembolic Pulmonary Hypertension
松原 広己先生 (岡山医療センター 臨床研究部)
2.Evolution of the PAH Patient Population over the Last Decade
Marc Humbert, (Le Plessis Robinson, France)
3.Recent Progress in Pulmonary Hypertension
大郷 剛先生(国立循環器病研究センター 心臓内科)
4.Therapeutic Management of PAH Patient
Marc Humbert, (Le Plessis Robinson, France)
※Nazzareno Galie先生がルフトハンザのストライキにより欠席
AHA-JCS Joint Symposiumのメンバー
■AHA2014(シカゴ)
Use of ES/iPS Cells for Cardiovascular Medicine
座長:Charles E Murry(Seattle, WA)
福田 恵一(慶應義塾大学 循環器内科)
演者:
1.Clinical Application of Induced Pluripotent Stem Cells for Heart Failure Treatment:
Potentials, Progress, and Obstacles
藤田 淳(慶應義塾大学 循環器内科)
2.Multiple Approaches for Cardiac Regeneration Using Pluripotent Stem Cells
山下 潤(京都大学)
3.Strategies for Myocardial Regeneration and Repair
William Pu(Boston, MA)
4.Human iPS Cells as Models of Heart Disease: What Have They Taught Us?
Joseph C Wu(Stanford, CA)
出典した日循ブースの様子
■AHA2013 (ジョイントシンポジウムなし)
■AHA2012(ロサンゼルス)
Walking Through Walls: Innovation in CTO Therapy
座長:Stephane Rinfret(Quebec City, QC, Canada)
Alice K Jacobs(Boston, MA)
尾崎 行男(藤田保健衛生大学 循環器内科)
演者:
1.Check Please! Opting for Coronary Artery Bypass Graft in CTO
碓氷 章彦(名古屋大学 胸部機能外科)
2.Novel Approaches to Walking Retrograde
森野 禎浩(岩手医科大学 内科学講座循環器内科分野)
3.Harnessing the Biology of CTOs: Creating New Pathways
Bradley Strauss(Toronto, ON, Canada)
■AHA2011 (ジョイントシンポジウムなし)
■AHA2010 (ジョイントシンポジウムなし)
■AHA2009(オーランド)
Challenges to Advanced Heart Failure: Beyond the Guidelines
座長:Mihai Gheorghiade
(Division of Cardiology, Northwestern University, Chicago, IL, USA)
室原 豊明(名古屋大学 循環器内科)
演者:
1.Waon Therapy for Heart Failure
鄭 忠和(鹿児島大学 心臓血管・高血圧内科学)
2.sulin resistance in heart failure: A new therapeutic target?
筒井 裕之(北海道大学 循環病態内科学)
3.Experimental Agents
James E Udelson
(Division of Cardiology and Nuclear Cardiology,
Tufts-New England Medical Center, Boston, MA, USA)
4.Mechanical Support
James B Young
(Division of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA)
■AHA2008(ニューオリンズ)
Cardiac Risk Prediction with Biomarkers: US and Japanese Populations
座長:Christine Albert(Boston, MA)
Robert Rosenson(Ann Arbor, MI)
演者:
1.CRP/BNP: Metabolic Syndrome and Biomarkers: Japanese Perspective
島田 俊夫(島根大学 循環器内科)
2.CRP/BNP: Metabolic Syndrome and Biomarkers: U.S. Perspective
Ramachandran Vasan(Framingham, MA)
3.New Biomarkers: Free Immunoglobulin Light Chains and Anti-troponin I Antibody: Japanese Perspective
松森 昭(京都大学 循環器内科)
4.New Biomarkers: Free Immunoglobulin Light Chains and Anti-troponin I Antibody: U.S.Perspective
Peter Libby(Boston, MA)
■AHA2007(オーランド)
PCI in the United States and Japan
座長:木村 剛(京都大学 循環器内科)
演者:
1.Chronic Total Occlusions: Japanese Perspective
加藤 廉(Toyohashi Heart Center Aichi, Japan)
2.Chronic Total Occlusions: US Perspective
Barry Rutherford(Mid Heart Institute, Kansas City, Missouri, USA)
3.BMS vs DES: Japanese Perspective
木村 剛(京都大学 循環器内科)
4.BMS vs DES: US Perspective
Ron Waksman(Medstar, Rockville, Maryland, USA)
■AHA2006(シカゴ)
Myocyte Death in Heart failure: Autophagy, Apoptosis and Necrosis
座長:Francis Klocke(Northwestern University)
小川 聡(Keio, Japan)
演者:
1.Apoptosis and Autophagy during Acute Ischemia
Jaget Narula
(Chief, Div. of Cardiology; Associate Dean, UC Irvine College of Medicine)
2.Preventing apoptosis and Autophagy
Hani Sabbah(Henry Ford Health System)
3.Vascular and Myocardial Apoptosis: Similarities and Differences
Nirat Beohar
(Division of Cardiology, Feinberg School of Medicine, Northwestern University)
4.Autophagy as a Mechanism of Heart Failure Progression
小室 一成(Chiba University)
5.Apoptosis and Autophagy in the Failing Heart
竹村 元三(朝日大学 総合医科学講座内科学)
■AHA2005(ダラス)
AHA/JCS Inflammation and Immune Response in Cardiomyopathy and Heart Failure
座長:Charles J Lowenstein(Baltimore, MD)
小川 聡(慶應義塾大学 循環器内科)
演者:
1.Anti-inflammatory and Immunomodulatory Therapy for Heart Failure
松森 昭(京都大学 循環器内科)
2.Gene Therapies for Immune-mediated Heart Diseases
磯部 光章(東京医科歯科大学 循環制御内科学)
3.Innate Immunity and its Role in Heart Failure
Douglas L Mann(Houston, TX)
4.Inflammatory Mediators and Post-MI Remodeling
Peter Liu(Toronto, Canada)
■AHA2004(ニューオリンズ)
Metabolic Syndrome and Cardiovascular Disease
座長:Robert H Eckel(Denver, USA)
小川 聡(慶應義塾大学 循環器内科)
演者:
1.The Role of the Adiponectin Receptor Pathway in Pathogenesis
門脇 孝(東京大学 糖尿病・代謝内科)
2.Molecular Target in the Metabolic Syndrome
下村 伊一郎(大阪大学 内分泌・代謝内科学)
3.Cardiovascular and Sympathetic Actions of Leptin:
Implications for Cardiovascular Disease in Obesity
Allyn L Mark(Iowa City, USA)
4.INTER-HEART Data on the Metabolic Syndrome
Salim D Yusuf(Hamilton, Canada)
■AHA2003(オーランド)
Introduction to Scientific Sessions 2003
座長:Raymond Gibbons
磯部 光章(東京医科歯科大学 循環制御内科学)
演者:
1.Clinical Overview
Jay N. Cohn(University of Minnesota, MN)
2.Basic Sciences Overview
Richard Walsh(University Hospital of Cleveland, OH)
3.Population Science and Clinical Trials Overview
Tom Pearson(University of Rochester, NY)
■AHA2002(シカゴ)
Introduction to Scientific Sessions 2002
座長:Augustus O. Grant(Durham, NC)
竹下 彰(福岡県済生会二日市病院)
演者:
1.Clinical Overview
Valentin Fuster
2.Basic Sciences Overview
Peter Libby
3.Population Science and Clinical Trials Overview
David Harrington
4.Meeting overview and changes for 2003 meeting
Augustus Grant(Durham, NC)
■AHA2001(アナハイム)
Introduction to Scientific Sessions 2001
座長:Augustus O. Grant(Durham, NC)
竹下 彰(福岡県済生会二日市病院)
演者:
1.Introduction
矢ア 義雄(独立行政法人国立病院機構)
2.Overview Including Clinical Trials
Augustus O. Grant(Durham, NC)
3.Clinical Science Highlights
Joseph S. Alpert(Tucson, AZ)
4.Basic Sciences Highlights
Michael D. Schneider(Houston, TX)
5.Population and Prevention Sciences Highlights
Lori Mosca(New York, NY)
■AHA2015(フロリダ)
Recent Progress in Pulmonary Hypertension
座長:Samuel Dudley (Provience, RI)
佐藤 徹先生(杏林大学 循環器内科)
演者:
1.Pulmonary Angioplasty as an Alternative Treatment for Inoperable Patients With
Chronic Thromboembolic Pulmonary Hypertension
松原 広己先生 (岡山医療センター 臨床研究部)
2.Evolution of the PAH Patient Population over the Last Decade
Marc Humbert, (Le Plessis Robinson, France)
3.Recent Progress in Pulmonary Hypertension
大郷 剛先生(国立循環器病研究センター 心臓内科)
4.Therapeutic Management of PAH Patient
Marc Humbert, (Le Plessis Robinson, France)
※Nazzareno Galie先生がルフトハンザのストライキにより欠席
■AHA2014(シカゴ)
Use of ES/iPS Cells for Cardiovascular Medicine
座長:Charles E Murry(Seattle, WA)
福田 恵一(慶應義塾大学 循環器内科)
演者:
1.Clinical Application of Induced Pluripotent Stem Cells for Heart Failure Treatment:
Potentials, Progress, and Obstacles
藤田 淳(慶應義塾大学 循環器内科)
2.Multiple Approaches for Cardiac Regeneration Using Pluripotent Stem Cells
山下 潤(京都大学)
3.Strategies for Myocardial Regeneration and Repair
William Pu(Boston, MA)
4.Human iPS Cells as Models of Heart Disease: What Have They Taught Us?
Joseph C Wu(Stanford, CA)
■AHA2013 (ジョイントシンポジウムなし)
■AHA2012(ロサンゼルス)
Walking Through Walls: Innovation in CTO Therapy
座長:Stephane Rinfret(Quebec City, QC, Canada)
Alice K Jacobs(Boston, MA)
尾崎 行男(藤田保健衛生大学 循環器内科)
演者:
1.Check Please! Opting for Coronary Artery Bypass Graft in CTO
碓氷 章彦(名古屋大学 胸部機能外科)
2.Novel Approaches to Walking Retrograde
森野 禎浩(岩手医科大学 内科学講座循環器内科分野)
3.Harnessing the Biology of CTOs: Creating New Pathways
Bradley Strauss(Toronto, ON, Canada)
■AHA2011 (ジョイントシンポジウムなし)
■AHA2010 (ジョイントシンポジウムなし)
■AHA2009(オーランド)
Challenges to Advanced Heart Failure: Beyond the Guidelines
座長:Mihai Gheorghiade
(Division of Cardiology, Northwestern University, Chicago, IL, USA)
室原 豊明(名古屋大学 循環器内科)
演者:
1.Waon Therapy for Heart Failure
鄭 忠和(鹿児島大学 心臓血管・高血圧内科学)
2.sulin resistance in heart failure: A new therapeutic target?
筒井 裕之(北海道大学 循環病態内科学)
3.Experimental Agents
James E Udelson
(Division of Cardiology and Nuclear Cardiology,
Tufts-New England Medical Center, Boston, MA, USA)
4.Mechanical Support
James B Young
(Division of Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA)
■AHA2008(ニューオリンズ)
Cardiac Risk Prediction with Biomarkers: US and Japanese Populations
座長:Christine Albert(Boston, MA)
Robert Rosenson(Ann Arbor, MI)
演者:
1.CRP/BNP: Metabolic Syndrome and Biomarkers: Japanese Perspective
島田 俊夫(島根大学 循環器内科)
2.CRP/BNP: Metabolic Syndrome and Biomarkers: U.S. Perspective
Ramachandran Vasan(Framingham, MA)
3.New Biomarkers: Free Immunoglobulin Light Chains and Anti-troponin I Antibody: Japanese Perspective
松森 昭(京都大学 循環器内科)
4.New Biomarkers: Free Immunoglobulin Light Chains and Anti-troponin I Antibody: U.S.Perspective
Peter Libby(Boston, MA)
■AHA2007(オーランド)
PCI in the United States and Japan
座長:木村 剛(京都大学 循環器内科)
演者:
1.Chronic Total Occlusions: Japanese Perspective
加藤 廉(Toyohashi Heart Center Aichi, Japan)
2.Chronic Total Occlusions: US Perspective
Barry Rutherford(Mid Heart Institute, Kansas City, Missouri, USA)
3.BMS vs DES: Japanese Perspective
木村 剛(京都大学 循環器内科)
4.BMS vs DES: US Perspective
Ron Waksman(Medstar, Rockville, Maryland, USA)
■AHA2006(シカゴ)
Myocyte Death in Heart failure: Autophagy, Apoptosis and Necrosis
座長:Francis Klocke(Northwestern University)
小川 聡(Keio, Japan)
演者:
1.Apoptosis and Autophagy during Acute Ischemia
Jaget Narula
(Chief, Div. of Cardiology; Associate Dean, UC Irvine College of Medicine)
2.Preventing apoptosis and Autophagy
Hani Sabbah(Henry Ford Health System)
3.Vascular and Myocardial Apoptosis: Similarities and Differences
Nirat Beohar
(Division of Cardiology, Feinberg School of Medicine, Northwestern University)
4.Autophagy as a Mechanism of Heart Failure Progression
小室 一成(Chiba University)
5.Apoptosis and Autophagy in the Failing Heart
竹村 元三(朝日大学 総合医科学講座内科学)
■AHA2005(ダラス)
AHA/JCS Inflammation and Immune Response in Cardiomyopathy and Heart Failure
座長:Charles J Lowenstein(Baltimore, MD)
小川 聡(慶應義塾大学 循環器内科)
演者:
1.Anti-inflammatory and Immunomodulatory Therapy for Heart Failure
松森 昭(京都大学 循環器内科)
2.Gene Therapies for Immune-mediated Heart Diseases
磯部 光章(東京医科歯科大学 循環制御内科学)
3.Innate Immunity and its Role in Heart Failure
Douglas L Mann(Houston, TX)
4.Inflammatory Mediators and Post-MI Remodeling
Peter Liu(Toronto, Canada)
■AHA2004(ニューオリンズ)
Metabolic Syndrome and Cardiovascular Disease
座長:Robert H Eckel(Denver, USA)
小川 聡(慶應義塾大学 循環器内科)
演者:
1.The Role of the Adiponectin Receptor Pathway in Pathogenesis
門脇 孝(東京大学 糖尿病・代謝内科)
2.Molecular Target in the Metabolic Syndrome
下村 伊一郎(大阪大学 内分泌・代謝内科学)
3.Cardiovascular and Sympathetic Actions of Leptin:
Implications for Cardiovascular Disease in Obesity
Allyn L Mark(Iowa City, USA)
4.INTER-HEART Data on the Metabolic Syndrome
Salim D Yusuf(Hamilton, Canada)
■AHA2003(オーランド)
Introduction to Scientific Sessions 2003
座長:Raymond Gibbons
磯部 光章(東京医科歯科大学 循環制御内科学)
演者:
1.Clinical Overview
Jay N. Cohn(University of Minnesota, MN)
2.Basic Sciences Overview
Richard Walsh(University Hospital of Cleveland, OH)
3.Population Science and Clinical Trials Overview
Tom Pearson(University of Rochester, NY)
■AHA2002(シカゴ)
Introduction to Scientific Sessions 2002
座長:Augustus O. Grant(Durham, NC)
竹下 彰(福岡県済生会二日市病院)
演者:
1.Clinical Overview
Valentin Fuster
2.Basic Sciences Overview
Peter Libby
3.Population Science and Clinical Trials Overview
David Harrington
4.Meeting overview and changes for 2003 meeting
Augustus Grant(Durham, NC)
■AHA2001(アナハイム)
Introduction to Scientific Sessions 2001
座長:Augustus O. Grant(Durham, NC)
竹下 彰(福岡県済生会二日市病院)
演者:
1.Introduction
矢ア 義雄(独立行政法人国立病院機構)
2.Overview Including Clinical Trials
Augustus O. Grant(Durham, NC)
3.Clinical Science Highlights
Joseph S. Alpert(Tucson, AZ)
4.Basic Sciences Highlights
Michael D. Schneider(Houston, TX)
5.Population and Prevention Sciences Highlights
Lori Mosca(New York, NY)